Newswise — In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.
The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions. Clinical trials could begin as soon as 2012.
Mick Bhatia, scientific director of McMaster’s Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine, and his team of researchers have also shown that the conversion is direct. Making blood from skin does not require the middle step of changing a skin stem cell into a pluripotent stem cell that could make many other types of human cells, then turning it into a blood stem cell.
“We have shown this works using human skin. We know how it works and believe we can even improve on the process,” said Bhatia. “We’ll now go on to work on developing other types of human cell types from skin, as we already have encouraging evidence.”
The discovery was replicated several times over two years using human skin from both young and old people to prove it works for any age of person.
This research was funded by the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, the Stem Cell Network and the Ontario Ministry of Research and Innovation.
John Kelton, hematologist and dean and vice-president of health sciences for McMaster University said: “I find this discovery personally gratifying for professional reasons.
"During my 30 years as a practicing blood specialist, my colleagues and I have been pleased to help care for cancer patients whose lives were saved by bone marrow transplants. For all physicians, but especially for the patients and their families, the illness became more frustrating when we were prevented from giving a bone marrow transplant because we could not find a perfect donor match in the family or the community.
“Dr. Bhatia’s discovery could permit us to help this important group of patients.”-30-
Backgrounder, bio, pictures and video interviews of Mick Bhatia and b-roll of the Stem Cell and Cancer Research Institute laboratories as well as an animation may be downloaded from: http://fhs.mcmaster.ca/media/sccri/media_20101106.htmlThe user name is: sccriThe password is: nature6739
Scientists and sponsors prepared to comment on the research findings under embargo include:
Alain Beaudet, MD, PhD, President, Canadian Institutes for Health Research, Ottawa, ON, CanadaInterviews may be arranged through: David Coulombe, T: 613-941-4563 orE: email@example.com or C: 613-808-7526 “CIHR is proud to invest in the excellent research that is being undertaken by Mick Bhatia’s laboratory at the Stem Cell and Cancer Research Institute at McMaster University,” said Alain Beaudet, president of the Canadian Institutes for Health Research.
“The Bhatia research effort is building on significant findings in recent years, which have shown that human skin cells can be reprogrammed into pluripotent cells that have the potential to become all cell types.
"The pioneering findings published today are the first to demonstrate that human skin cells can be directly converted into blood cells, via a programming process that bypasses the pluripotent stage. Producing blood from a patient’s own skin cells, has the potential of making bone marrow transplant HLA matching and paucity of donors a thing of the past.”
Cynthia Dunbar, MD, Head, Molecular Hematopoiesis Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USAInterviews may be arranged through: Kristin Weichman, T: 301-496-1434 or E: firstname.lastname@example.org
"Bhatia's convincing demonstration that skin cells can be directly converted to hematopoietic progenitor cells is exciting and will immediately change the paradigms regarding the best way forward for production of hematopoietic cells to be used in regenerative medicine and in the study of human blood diseases,” said Cynthia Dunbar, head of the molecular hematopoiesis section of the National Heart, Lung and Blood Institute of the National Institutes of Health in the U.S.
“Bhatia's approach detours around the pluripotent stem cell stage and thus avoids many safety issues, increases efficiency, and also has the major benefit of producing adult-type l blood cells instead of fetal blood cells, a major advantage compared to the thus far disappointing attempts to produce blood cells from human ESCs or IPSCs."
Christine Williams, PhD, Director of Research, Canadian Cancer Society Research Institute, Toronto, ON, CanadaInterviews may be arranged through: Christine Harminc T: 416-934-5650 or E: CHarminc@cancer.ca
"We are happy to be able to fund this important stem cell research which holds enormous promise for improved treatment of many types of cancer, including solid tumours and leukemias," said Christine Williams, director of research for the Canadian Cancer Society Research Institute.
Michael Rudnicki, PhD, Director, Stem Cell Network, Ottawa, ON, CanadaInterviews may be arranged through: Lisa Willemse, T: 613-739-6673 or E: email@example.com or C: 613-304-2108 “This finding will no doubt be met with excitement in the research and medical communities. It's been nearly 50 years since blood stem cells were first identified here in Canada and it's fitting that this incredible new discovery should have happened here as well," said Michael Rudnicki, director of the Stem Cell Network.
Guy Sauvageau, MD, PhD, Chief Executive Officer and Scientific Director, Institute for Research in Immunology and Cancer, University of MontrealInterviews may be arranged through: Veronica McGuire T: 905-525-9140, ext. 22169 or E: firstname.lastname@example.org
Samuel Weiss, PhD, Professor and Director, Hotchkiss Brain Institute, University of CalgaryDr. Weiss is not available for interviews until Monday, Nov. 8. At that time he may be reached through: Veronica McGuire T: 905-525-9140, ext. 22169 or E: email@example.com
“This groundbreaking work from Mick Bhatia’s lab is both fascinating and important. It heralds a new age by discovering a role for ‘directed differentiation’ in the treatment of cancers and other disorders of the blood and immune system,” said Sam Weiss, professor and director of the Hotchkiss Brain Institute at the University of Calgary.